Annual Current Liabilities
$10.81 M
-$4.18 M-27.88%
December 31, 2023
Summary
- As of February 8, 2025, SABS annual total current liabilities is $10.81 million, with the most recent change of -$4.18 million (-27.88%) on December 31, 2023.
- During the last 3 years, SABS annual current liabilities has fallen by -$248.40 thousand (-2.25%).
- SABS annual current liabilities is now -59.13% below its all-time high of $26.46 million, reached on December 31, 2021.
Performance
SABS Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$8.82 M
+$1.26 M+16.74%
September 30, 2024
Summary
- As of February 8, 2025, SABS quarterly total current liabilities is $8.82 million, with the most recent change of +$1.26 million (+16.74%) on September 30, 2024.
- Over the past year, SABS quarterly current liabilities has dropped by -$394.70 thousand (-4.29%).
- SABS quarterly current liabilities is now -66.68% below its all-time high of $26.46 million, reached on December 31, 2021.
Performance
SABS Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
SABS Current Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -27.9% | -4.3% |
3 y3 years | -2.3% | -48.5% |
5 y5 years | +134.2% | -48.5% |
SABS Current Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -59.1% | at low | -66.7% | +16.7% |
5 y | 5-year | -59.1% | +134.2% | -66.7% | +2634.6% |
alltime | all time | -59.1% | +134.2% | -66.7% | +2634.6% |
SAB Biotherapeutics Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $8.82 M(+16.7%) |
Jun 2024 | - | $7.55 M(-9.1%) |
Mar 2024 | - | $8.30 M(-23.2%) |
Dec 2023 | $10.81 M(-27.9%) | $10.81 M(+17.4%) |
Sep 2023 | - | $9.21 M(-16.3%) |
Jun 2023 | - | $11.01 M(-19.4%) |
Mar 2023 | - | $13.67 M(-8.9%) |
Dec 2022 | $14.99 M | $14.99 M(-12.3%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2022 | - | $17.10 M(+6.0%) |
Jun 2022 | - | $16.14 M(-11.6%) |
Mar 2022 | - | $18.26 M(-31.0%) |
Dec 2021 | $26.46 M(+139.2%) | $26.46 M(+8105.7%) |
Sep 2021 | - | $322.40 K(-96.8%) |
Jun 2021 | - | $10.20 M(-7.8%) |
Dec 2020 | $11.06 M(+139.5%) | $11.06 M |
Dec 2019 | $4.62 M | - |
FAQ
- What is SAB Biotherapeutics annual total current liabilities?
- What is the all time high annual current liabilities for SAB Biotherapeutics?
- What is SAB Biotherapeutics annual current liabilities year-on-year change?
- What is SAB Biotherapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for SAB Biotherapeutics?
- What is SAB Biotherapeutics quarterly current liabilities year-on-year change?
What is SAB Biotherapeutics annual total current liabilities?
The current annual current liabilities of SABS is $10.81 M
What is the all time high annual current liabilities for SAB Biotherapeutics?
SAB Biotherapeutics all-time high annual total current liabilities is $26.46 M
What is SAB Biotherapeutics annual current liabilities year-on-year change?
Over the past year, SABS annual total current liabilities has changed by -$4.18 M (-27.88%)
What is SAB Biotherapeutics quarterly total current liabilities?
The current quarterly current liabilities of SABS is $8.82 M
What is the all time high quarterly current liabilities for SAB Biotherapeutics?
SAB Biotherapeutics all-time high quarterly total current liabilities is $26.46 M
What is SAB Biotherapeutics quarterly current liabilities year-on-year change?
Over the past year, SABS quarterly total current liabilities has changed by -$394.70 K (-4.29%)